LBA9 TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis

• DOI: 10.1016/j.annonc.2024.10.830
• Publication Date: 2024-12-08T04:56:03Z
• Authors: P. Grivas; T.B. Powles; C. Vulsteke; M. Gross Goupil; S.H. Park; A. Necchi; M. De Santis; I. Duran; R. Morales Barrera; J. Guo; C.N. Sternberg; J. Bellmunt; P.J. Goebell; F. Boateng; M. Sierecki; L. Wang; C. Sima; J. Waldes; S.T. Tagawa; Y. Loriot